Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
FLAMSA-BU regimen
Introduction
Overview
Overview
FLAMSA-BU regimen refers to a regimen consisting of fludarabine, amsacrine, cytarabine (Ara-C) and busulfan used as a sequential conditioning therapy for previously untreated patients with high-risk myelodysplastic syndrome (MDS) or acute myelogenous leukemia secondary to MDS (sAML).[1]
Regimen
Regimen
FLFludarabine
AMSAmsacrine
ACytarabine (Ara-C)
BUBusulfan
Indications
Indications
- Untreated, high-risk myelodysplastic syndrome (MDS) or acute myelogenous leukemia secondary to MDS (sAML)[1]
References
References
- ↑ 1.0 1.1 Saure C, Schroeder T, Zohren F, Groten A, Bruns I, Czibere A; et al. (2012). “Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen”. Biol Blood Marrow Transplant. 18 (3): 466–72. doi:10.1016/j.bbmt.2011.09.006. PMID 21963618.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]